$40.75
-0.36[-0.88%]
At close: May 30
$40.75
0[0.00%]
After Hours: 4:27PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No data available to display |
There have been no specific sales or earnings guidance reported for Apellis Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.